Adults 18 to 65, any sex, with Dentin Hypersensitivity or Dentin Sensitivity. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Mean Schiff Sensitivity Score (Average of the Two Selected Test Teeth) at Baseline (Day 0)Primary· Baseline (Day 0)
Evaporative air sensitivity was assessed on facial surfaces of eligible incisor,canine and pre-molar teeth by directing a one second application of air from standard dental syringe held perpendicular to tooth surface, approximately 1-2 millimeter (mm) coronal to the gingival margin from a distance of approximately 1 centimeter (cm).Participant response to the stimulus was evaluated using the Schiff sensitivity scale, an examiner-based index scored immediately following administration of the evaporative air stimulus.0=Does not respond to air stimulation;1=Responds to air stimulus but does not r
Group
Value
95% CI
Test Dentifrice
2.61
± 0.063
Control Dentifrice
2.60
± 0.063
Mean Schiff Sensitivity Score (Average of the Two Selected Test Teeth) at Day 3Primary· Day 3
Evaporative air sensitivity was assessed on facial surfaces of eligible incisor,canine and pre-molar teeth by directing a one second application of air from a standard dental syringe held perpendicular to the tooth surface, approximately 1-2 mm coronal to the gingival margin, and from a distance of approximately 1 cm. Participant response to the stimulus was evaluated using the Schiff sensitivity scale, an examiner-based index scored immediately following administration of the evaporative air stimulus. 0=Does not respond to air stimulation;1=Responds to air stimulus but does not request discon
Group
Value
95% CI
Test Dentifrice
1.19
± 0.104
Control Dentifrice
1.46
± 0.104
Mean Schiff Sensitivity Score (Average of the Two Selected Test Teeth) at Day 7Primary· Day 7
Evaporative air sensitivity was assessed on facial surfaces of eligible incisor,canine and pre-molar teeth by directing a one second application of air from a standard dental syringe held perpendicular to the tooth surface, approximately 1-2 mm coronal to the gingival margin, and from a distance of approximately 1 cm. Participant response to the stimulus was evaluated using the Schiff sensitivity scale, an examiner-based index scored immediately following administration of the evaporative air stimulus. 0=Does not respond to air stimulation;1=Responds to air stimulus but does not request discon
Group
Value
95% CI
Test Dentifrice
0.73
± 0.097
Control Dentifrice
1.20
± 0.120
Mean Schiff Sensitivity Score (Average of the Two Selected Test Teeth) at Day 14Primary· Day 14
Evaporative air sensitivity was assessed on facial surfaces of eligible incisor,canine and pre-molar teeth by directing a one second application of air from a standard dental syringe held perpendicular to the tooth surface, approximately 1-2 mm coronal to the gingival margin, and from a distance of approximately 1 cm. Participant response to the stimulus was evaluated using the Schiff sensitivity scale, an examiner-based index scored immediately following administration of the evaporative air stimulus. 0=Does not respond to air stimulation;1=Responds to air stimulus but does not request discon
Group
Value
95% CI
Test Dentifrice
0.52
± 0.085
Control Dentifrice
1.07
± 0.134
Mean Schiff Sensitivity Score (Average of the Two Selected Test Teeth) at Day 28Primary· Day 28
Evaporative air sensitivity was assessed on facial surfaces of eligible incisor,canine and pre-molar teeth by directing a one second application of air from a standard dental syringe held perpendicular to the tooth surface, approximately 1-2 mm coronal to the gingival margin, and from a distance of approximately 1 cm. Participant response to the stimulus was evaluated using the Schiff sensitivity scale, an examiner-based index scored immediately following administration of the evaporative air stimulus. 0=Does not respond to air stimulation;1=Responds to air stimulus but does not request discon
Group
Value
95% CI
Test Dentifrice
0.32
± 0.087
Control Dentifrice
0.75
± 0.121
Mean Schiff Sensitivity Score (Average of the Two Selected Test Teeth) at Day 56Primary· Day 56
Evaporative air sensitivity was assessed on facial surfaces of eligible incisor,canine and pre-molar teeth by directing a one second application of air from a standard dental syringe held perpendicular to the tooth surface, approximately 1-2 mm coronal to the gingival margin, and from a distance of approximately 1 cm. Participant response to the stimulus was evaluated using the Schiff sensitivity scale, an examiner-based index scored immediately following administration of the evaporative air stimulus. 0=Does not respond to air stimulation;1=Responds to air stimulus but does not request discon
Group
Value
95% CI
Test Dentifrice
0.12
± 0.043
Control Dentifrice
0.42
± 0.100
Mean Tactile Threshold (Average of the Two Selected Test Teeth) at Baseline (Day 0)Primary· Baseline (Day 0)
Tactile sensitivity was assessed for eligible incisor,canine and pre-molar teeth using a constant pressure probe (Yeaple probe),starting at 10 gram (g) and rising in increments of 10 g until the tactile threshold or maximum force for that visit is reached.The probe tip was placed perpendicular to the facial surface of tooth and drawn slowly across the exposed dentine.After each application,the participant was asked to indicate whether they experienced any pain or discomfort (yes/no response).The pressure setting at which participant gave two consecutive 'yes' responses was recorded as the tact
Group
Value
95% CI
Test Dentifrice
11.06
± 0.372
Control Dentifrice
12.31
± 0.574
Mean Tactile Threshold (Average of the Two Selected Test Teeth) at Day 3Primary· Day 3
Tactile sensitivity was assessed for eligible incisor, canine and pre-molar teeth using a constant pressure probe (Yeaple probe),starting at 10 g and rising in increments of 10 g until the tactile threshold or maximum force for that visit is reached. The probe tip was placed perpendicular to the facial surface of tooth and drawn slowly across the exposed dentine.After each application, the participant was asked to indicate whether they experienced any pain or discomfort (yes/no response). The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the tac
Group
Value
95% CI
Test Dentifrice
31.35
± 2.087
Control Dentifrice
27.98
± 2.061
Mean Tactile Threshold (Average of the Two Selected Test Teeth) at Day 7Primary· Day 7
Tactile sensitivity was assessed for eligible incisor, canine and pre-molar teeth using a constant pressure probe (Yeaple probe),starting at 10 g and rising in increments of 10 g until the tactile threshold or maximum force for that visit is reached. The probe tip was placed perpendicular to the facial surface of tooth and drawn slowly across the exposed dentine.After each application, the participant was asked to indicate whether they experienced any pain or discomfort (yes/no response). The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the tac
Group
Value
95% CI
Test Dentifrice
47.45
± 3.075
Control Dentifrice
38.75
± 2.983
Mean Tactile Threshold (Average of the Two Selected Test Teeth) at Day 14Primary· Day 14
Tactile sensitivity was assessed for eligible incisor, canine and pre-molar teeth using a constant pressure probe (Yeaple probe),starting at 10 g and rising in increments of 10 g until the tactile threshold or maximum force for that visit is reached. The probe tip was placed perpendicular to the facial surface of tooth and drawn slowly across the exposed dentine.After each application, the participant was asked to indicate whether they experienced any pain or discomfort (yes/no response). The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the tac
Group
Value
95% CI
Test Dentifrice
60.59
± 3.271
Control Dentifrice
48.53
± 3.549
Mean Tactile Threshold (Average of the Two Selected Test Teeth) at Day 28Primary· Day 28
Tactile sensitivity was assessed for eligible incisor, canine and pre-molar teeth using a constant pressure probe (Yeaple probe),starting at 10 g and rising in increments of 10 g until the tactile threshold or maximum force for that visit is reached. The probe tip was placed perpendicular to the facial surface of tooth and drawn slowly across the exposed dentine.After each application, the participant was asked to indicate whether they experienced any pain or discomfort (yes/no response). The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the tac
Group
Value
95% CI
Test Dentifrice
71.67
± 3.044
Control Dentifrice
57.94
± 4.076
Mean Tactile Threshold (Average of the Two Selected Test Teeth) at Day 56Primary· Day 56
Tactile sensitivity was assessed for eligible incisor, canine and pre-molar teeth using a constant pressure probe (Yeaple probe),starting at 10 g and rising in increments of 10 g until the tactile threshold or maximum force for that visit is reached. The probe tip was placed perpendicular to the facial surface of tooth and drawn slowly across the exposed dentine.After each application, the participant was asked to indicate whether they experienced any pain or discomfort (yes/no response). The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the tac
Group
Value
95% CI
Test Dentifrice
79.71
± 2.390
Control Dentifrice
64.80
± 3.921
Adverse events — posted to ClinicalTrials.gov
Time frame: From screening up to Day 56.
Reporting threshold: 0%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
This exploratory study will characterize the efficacy profile of an experimental dual active 5 percent (%) potassium nitrate/0.454% stannous fluoride dentifrice, compared to a single active 0.454% stannous fluoride desensitizing dentifrice, over an 8-week treatment period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT06216262 — Evaluation of the Effectiveness of Home-Use Desensitizing Agents on Dentin Hypersensitivity
· NA
· completed
NCT04913805 — Matching Perfusion and Metabolic Activity in HFpEF
· Phase 2
· recruiting
NCT03627130 — The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
· Phase 2
· completed
NCT03483051 — Targeting Pulsatile Load to Increase Exercise Capacity and Quality of Life After Aortic Valve Replacement for Severe Aor
· Phase 2
· completed
Other recruiting trials for Dentin Hypersensitivity
Currently open trials in the same condition.
NCT07431736 — Laser Therapy for Dentin Hypersensitivity
· NA
· active not recruiting
NCT07069127 — Hydroxyapatite-Based Home Treatment for Dentin Sensitivity in Celiac Patients
· NA
· recruiting
NCT07113847 — Effectiveness of Resin-Based Desensitizer and Laser, Compared to Fluoride Varnish in Management of Dentine Hypersensitiv
· Phase 2, PHASE3
· active not recruiting
Other GlaxoSmithKline trials
Trials by the same sponsor.
NCT07569081 — A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflam
· Phase 2, PHASE3
· not yet recruiting
NCT07406347 — A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose
· Phase 1
· not yet recruiting
NCT07286266 — A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEH
· Phase 3
· not yet recruiting
NCT07286331 — A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Recurrent Endometrial Cancer (BEHOLD-E
· Phase 3
· not yet recruiting
NCT07406334 — A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months
· Phase 1
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by GlaxoSmithKline
Last refreshed: 11 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03943095.